On the evening of February 28, Liaoning Chengda announced that the general election of the new board of directors was completed, and the controlling shareholder was changed from Liaoning State-owned Assets Management Co., Ltd. to Shaoguan Gaoteng Enterprise Management Co., Ltd. (hereinafter referred to as "Shaoguan Gaoteng"), and the actual controller was changed from Liaoning State-owned Assets Supervision and Administration Commission to no actual controller.

Shaoguan Gaoteng is the largest shareholder of Liaoning Chengda, with a shareholding ratio of 15.30%, and is a wholly-owned subsidiary of Guangdong Private Investment Co., Ltd. (hereinafter referred to as "Yuemin Investment"), which has a relatively dispersed shareholding structure and no actual controller.

On the 28th, Liaoning Chengda held a general meeting of shareholders to deliberate and approve the relevant proposals for the general election of the board of directors. Xu Biao, Shang Shuzhi, Zhang Shanwei and Liu Zhihua, nominated by Shaoguan Gaoteng, were elected as directors of the company, accounting for 2/3 of the total number of non-independent directors.

On the same day, the company also held a board meeting to elect a new management. Among them, Xu Biao from Yuemin Investment was elected as the chairman and legal representative, Shang Shuzhi, chairman of Liaoning Chengdayuan, served as honorary chairman, Zhang Shanwei was promoted from vice president to president, and the board of directors of Liaoning Chengda appointed Zhu Hao, Wang Bin, Pei Shaohui, Qiu Chuang, and Zhou Yue as vice presidents for a term of three years.

From the perspective of the background of the new management team members, there are not only representatives of the original management, but also core executives with the background of Yuemin Investment to join. In this regard, Xu Biao, the new chairman, said that the combination of the old and the new is conducive to the continuity of the company's business development and the complementary advantages of the management team members with diverse backgrounds.

So, what new changes will the change of the board of directors and the change of controlling shareholders bring to Liaoning Chengda, and what is the strategic plan for the company's future development? With these questions, the first financial reporter interviewed the new chairman Xu Biao and the new president Zhang Shanwei.

Xu Biao said that on the one hand, the business will focus on the field of new quality productivity, with biopharmaceuticals as the core, strengthen vaccine research and development and international layout, and simultaneously improve the operational efficiency of supply chain services (trade) and energy development; On the other hand, the company will rely on the resources of the Yuemin Investment platform to promote Liaoning Chengda to become the core carrier of industrial operation, and if the conditions are suitable in the future, it can also expand the industrial chain through mergers and acquisitions. For specific strategic planning, you can pay attention to the company's future announcements.

How to synergize the industrial resources of Guangdong Mintou with the existing business of Liaoning Chengda? Xu Biao said that in the field of biomedicine, combined with the resources of Yuemin Investment in the field of life sciences, it will help the research and development of Chengda Bio's product pipeline and accelerate the international layout, and also promote the cooperation between Chengda Biotechnology and Yuemin Investment. In the field of supply chain, with the help of Yuemin Investment's experience and resources in the fields of big data and Internet of Things, it can promote the digital and intelligent upgrading of Liaoning Chengda supply chain services, optimize logistics efficiency and expand value-added services; In terms of energy layout, we can combine Yuemintou's investment experience in the field of new energy to explore the technological upgrading and green transformation of Liaoning Chengda's energy development sector.

According to public information, the paid-in capital of Yuemin Investment is 16 billion yuan, and its shareholders include Midea Group, Liby Group, Infore Group, Jiadu Group, Haitian Group, Kingfa Technology, Huamei Group, Wanhe Group, Huaxin Group and other enterprises in the Pearl River Delta, mainly investing in new energy, life science, agricultural modernization, large consumption, high-end manufacturing and other industrial fields related to scientific and technological innovation and green development.

Liaoning Chengda's business is divided into four major sectors: medicine and medical care, financial investment, supply chain services (trade) and energy development. Among them, the biopharmaceutical business is led by the subsidiary Chengda Biotech (688739. SH) is responsible for carrying out; In terms of financial investment, the long-term investment business is a shareholding in GF Securities and China Insurance, and the fund business is carried out by two shareholding companies, Huagai Capital Co., Ltd. and Chengda Coastal Industry (Dalian) Fund Management Co., Ltd.; In terms of supply chain service business, the Company, through its subsidiaries Chengda International, Chengda Iron and Steel and Chengda Trading, carries out the export of textiles and apparel, as well as the domestic trade and import and export business of bulk commodities such as coal and grain.

It is worth noting that the management was authorized to dispose of no more than 3% of the A-shares of GF Securities, which has attracted great attention from the market. Because of the shareholding of GF Securities, it is the main contributor to the performance of Liaoning Chengda.

In this regard, Zhang Shanwei told the first financial reporter that there are two main considerations, one is to appropriately reduce the scale of liabilities and increase the company's cash reserves; The second is to appropriately allocate resources, which can be used as a resource reserve for the company to implement a new round of development strategy in the next step, expand new business, focus on industry and new quality productivity. However, even after the disposal of the above-mentioned shares, Liaoning Chengda is still the second largest shareholder of GF Securities.

In addition to the above-mentioned authorized disposal, will Liaoning Chengda consider divesting non-core assets in the future?

"The decision to divest non-core assets will be dynamically adjusted based on the policy environment and actual business performance." Zhang Shanwei said that for inefficient assets and weak profitable businesses, Liaoning Chengda will take a variety of measures such as optimization, revitalization and integration to further improve Liaoning Chengda's capital utilization efficiency and diversified operation capabilities.

After Yuemin invested in Liaoning Chengda, it still faced a major problem, that is, how to solve the problem of pressure on the performance of Liaoning Chengda and Chengda Biology.

Xu Biao said that Yuemin Investment can empower the two companies to help improve performance through the following aspects: first, revitalize assets, integrate resources, and concentrate resources to expand new productivity businesses such as biomedicine; the second is to optimize the asset-liability structure and enhance the resilience of corporate financing; The third is to release synergies, with the help of the resources of Yuemin Investment's shareholders, expand the supply chain service customer network, and improve the scale of trade business.